Segment 8 - Future of Innovation and Treatment CostsByFebruary 18th 2014In the concluding segment, Dr Fendrick asks the panel to provide closing remarks about the future of treating hepatitis C (HCV). Dr Afdal says he believes this is a moment in time where a revolution is taking place.
Participating Faculty: Addressing Adherence Challenges Associated With Antiretroviral Therapy: Focus on Noninfectious DiarrheaBySeptember 30th 2013
HIV/AIDS Activists Hoping Anxiously that Healthcare Law Survives Supreme Court ReviewByApril 26th 2012